JUMPSEAT
AEROSPACE NEWS

Redwire Partners with SpaceX for Microgravity Research

Key Takeaways
  • Redwire's SpaceMD to fly dedicated Starfall mission.
  • Mission to carry up to 32 PIL-BOX experiment packages.
  • Starfall offers highly tailorable microgravity environment.
  • Mission scheduled to launch in late 2028.
Sign in to view key takeaways Get full access to in-depth analysis and key takeaways.
Sign In
Silver membership required Upgrade to Silver to access Key Takeaways.
Upgrade
Strategic Implications

This partnership may indicate a significant expansion of commercial microgravity research capabilities, which could accelerate the development of life-changing therapies. The involvement of SpaceX suggests a competitive threat to other startups in the reentry spacecraft market, but also validates the growing interest in microgravity research and manufacturing.

Sign in to view strategic implications Get full access to strategic analysis and expert insights.
Sign In
Silver membership required Upgrade to Silver to access Strategic Implications.
Upgrade

What Happened

Dedicated Starfall Mission to Advance Pharmaceutical Development

Redwire’s subsidiary, Space Microgravity Development, has signed an agreement with SpaceX to fly microgravity research payloads on the Starfall reentry vehicle. The dedicated mission, scheduled to launch in late 2028, will carry up to 32 of Redwire’s Pharmaceutical In-Space Laboratory experiment packages. The partnership aims to take advantage of Starfall’s highly tailorable microgravity environment and mission duration to perform pharmaceutical research. According to Redwire, this mission will be the largest dedicated commercial microgravity research mission to date, as reported by SpaceNews.

Source | Originally Published: August 6, 2024

Advertisement 728 × 90
JUMPSEAT
AEROSPACE NEWS
JUMPSEAT
AEROSPACE NEWS

Redwire Partners with SpaceX for Microgravity Research

Sponsored by: Jumpseat Solutions
Key Takeaways
  • Redwire's SpaceMD to fly dedicated Starfall mission.
  • Mission to carry up to 32 PIL-BOX experiment packages.
  • Starfall offers highly tailorable microgravity environment.
  • Mission scheduled to launch in late 2028.
Sign in to view key takeaways Get full access to in-depth analysis and key takeaways.
Sign In
Silver membership required Upgrade to Silver to access Key Takeaways.
Upgrade
Strategic Implications

This partnership may indicate a significant expansion of commercial microgravity research capabilities, which could accelerate the development of life-changing therapies. The involvement of SpaceX suggests a competitive threat to other startups in the reentry spacecraft market, but also validates the growing interest in microgravity research and manufacturing.

Sign in to view strategic implications Get full access to strategic analysis and expert insights.
Sign In
Silver membership required Upgrade to Silver to access Strategic Implications.
Upgrade

What Happened

Dedicated Starfall Mission to Advance Pharmaceutical Development

Redwire’s subsidiary, Space Microgravity Development, has signed an agreement with SpaceX to fly microgravity research payloads on the Starfall reentry vehicle. The dedicated mission, scheduled to launch in late 2028, will carry up to 32 of Redwire’s Pharmaceutical In-Space Laboratory experiment packages. The partnership aims to take advantage of Starfall’s highly tailorable microgravity environment and mission duration to perform pharmaceutical research. According to Redwire, this mission will be the largest dedicated commercial microgravity research mission to date, as reported by SpaceNews.

Source | Originally Published: August 6, 2024

Advertisement 300 × 250 Google AdSense